News of our $1.9 million hydroxyurea adherence NIH grant with the Research Institute at Nationwide Children's Hospital was among the top ten most-read articles on Sickle Cell Disease News. 

The Small Business Innovation Research (SBIR) grant from the National Heart, Lung, and Blood Institute supports our efforts to help children and teenagers living with sickle cell disease (SCD) improve their health and quality of life through increased adherence to hydroxyurea treatment via our technology. 

Sickle Cell Disease News is a digital platform intended to provide the SCD community with the most recent news and information on SCD and first-hand community perspectives from patient and caregiver columnists.

See the full list.